Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rLH Pre-treatment in Poor Ovarian Responders (PRE-LH)
NCT03741699Phase 3Completed
- Sponsor
- IVI
- Start
- Feb 2019
- Primary completion
- May 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of lutropin alfa in female infertility, sponsored by IVI. Started Feb 2019; status: completed.
02
Drugs
lutropin alfa
03
Conditions
female infertility
Beyond the preview
Go deeper on NCT03741699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03741699.